Colorectal cancer (CRC) is the third most common cancer in the world. Although there are
standard treatment options for CRC, most patients respond poorly to these treatments …

Sorafenib, a first-line molecular-target drug for advanced hepatocellular carcinoma (HCC),
has been shown to be a potent ferroptosis inducer in HCC. However, we found that there …

Abstract N6-methyladenosine (m6A) is the most abundant RNA modification in eukaryotes,
and it participates in the regulation of pathophysiological processes in various diseases …

Abstract N6-methyladenosine (m6A) is the most prevalent and well-characterized internal
chemical modification in eukaryotic RNA, influencing gene expression and phenotypic …

Long non-coding RNAs (lncRNAs) play critical functions in various cancers. Firre intergenic
repeating RNA element (FIRRE), a lncRNA located in the nucleus, was overexpressed in …

Colorectal cancer (CRC) is among the most frequent cancers and is associated with high
mortality particularly when being diagnosed in advanced stages. Although several …

Abstract N 6-methyladenosine (m6A) is a eukaryotic post-transcriptional modification
involved in cell growth and developmental processes, including RNA transcription …

Long non-coding RNAs (lncRNAs) play significant roles in different biological functions of
cancers. However, their function in the metabolism of glucose in patients with human …

Background Musculoskeletal disorder (MSD) are a class of inflammatory and degener‐ative
diseases, but the precise molecular mechanisms are still poorly understood. Noncoding …

Long noncoding RNAs (lncRNAs) emerge as essential roles in the regulation of alternative
splicing (AS) in various malignancies. Serine-and arginine-rich splicing factor 1 (SRSF1) …